Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:16 PM
Ignite Modification Date:
2025-12-24 @ 5:16 PM
NCT ID:
NCT00861250
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic multiple myeloma
* Age 18-65 years
* Written informed consent
Exclusion Criteria:
* WHO performance status ≥ 2, unless related to MM
* Severe cardiac dysfunction
* History of hypotension
* Serious medical or psychiatric illness
* Severe hepatic dysfunction
* Severe polyneuropathy ≥ grade 2
* Active, uncontrolled infection
* Previously treated with chemotherapy or extensive radiotherapy for MM
* Known HIV positivity
* Severe renal dysfunction with need of dialyses
* History of active cancer during past 5 years, except non-melanoma skin cancer or stage 0 cervical cancer
* Female patients who are pregnant or nursing
* Male or female patients of reproductive potential who are not practising effective means of contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00861250
Study Brief:
Protocol Section:
NCT00861250